27597
辅酶Q9
≥96.0% (HPLC)
别名:
Q-9, 泛醌-45, 泛醌-9
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C54H82O4
化学文摘社编号:
分子量:
795.23
UNSPSC Code:
12352204
NACRES:
NA.51
PubChem Substance ID:
MDL number:
Beilstein/REAXYS Number:
1900081
产品名称
辅酶Q9, ≥96.0% (HPLC)
InChI
1S/C54H82O4/c1-40(2)22-14-23-41(3)24-15-25-42(4)26-16-27-43(5)28-17-29-44(6)30-18-31-45(7)32-19-33-46(8)34-20-35-47(9)36-21-37-48(10)38-39-50-49(11)51(55)53(57-12)54(58-13)52(50)56/h22,24,26,28,30,32,34,36,38H,14-21,23,25,27,29,31,33,35,37,39H2,1-13H3/b41-24+,42-26+,43-28+,44-30+,45-32+,46-34+,47-36+,48-38+
SMILES string
COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(\C)C)=C(C)C1=O
InChI key
UUGXJSBPSRROMU-WJNLUYJISA-N
assay
≥96.0% (HPLC)
form
powder
application(s)
cell analysis
storage temp.
−20°C
Quality Level
正在寻找类似产品? 访问 产品对比指南
Application
辅酶 Q9（泛醌-9;Ubi-9）可能用于体内和体外泛醌类的研究 。辅酶 Q9 可用作分析方法中的引用化合物，用于监测各种生理和病理条件下以及食品储备中的特定泛醌水平。
辅酶 Q9已被用于研究其对荧光分光光度法（FS-ECA）辅酶 Q10 (CoQ10) 检测的干扰。它还被用作对应于不同遗传疾病的不同生物样品的色谱分析中的分析物。
Biochem/physiol Actions
辅酶Q（CoQ）可以行使多种功能，例如电子和质子传递。辅酶9行使的功能与秀丽隐杆线虫（Caenorhabditis elegan）中天然辅酶辅酶10的功能类似。辅酶Q9及其他辅酶Q分子可能对细胞寿命产生影响，并且这些分子在此类研究中的应用正在增多。
General description
辅酶Q9（泛醌-9; Ubi-9）是泛醌家族的9异戊二烯基成员，这些泛醌均有一个奎宁化学基团，但尾部异戊二烯基化学亚基的数量不同。辅酶Q化合物是细胞膜的脂溶性成分。
Other Notes
脂质体系统中的高效电子和质子转运器； 防止小鼠和家兔出现阿霉素 ® 相关的心脏毒性现象。
Packaging
无底玻璃瓶。内含物装在插入的融合锥内。
Legal Information
Adriamycin is a registered trademark of RDF Pharmacia & Upjohn S.P.A.
存储类别
11 - Combustible Solids
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
A rapid and non-invasive fluorescence method for quantifying coenzyme Q10 in blood and urine in clinical analysis
Fei X, et al.
Journal of Clinical Laboratory Analysis, e23130-e23130 (2019)
Adriamycin associated cardiotoxicity: research on prevention with coenzyme Q.
C Bertazzoli et al.
Pharmacological research communications, 9(3), 235-250 (1977-03-01)
Lidiya Bebrevska et al.
Journal of ethnopharmacology, 127(1), 112-117 (2009-10-06)
Oxidative stress has been associated with many pathological disorders such as atherosclerosis, diabetes and cancer. Supplementation with exogenous antioxidants, including phenolic compounds from plant sources, may help to restore the pro-oxidative/antioxidative balance. To take into account effects of absorption, metabolisation
G. Hauska
Dev. Bioenerg. Biomembr., 1, 177-177 (1977)
Rohit Kohli et al.
Hepatology (Baltimore, Md.), 52(3), 934-944 (2010-07-08)
Diets high in saturated fat and fructose have been implicated in the development of obesity and nonalcoholic steatohepatitis (NASH) in humans. We hypothesized that mice exposed to a similar diet would develop NASH with fibrosis associated with increased hepatic oxidative
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持